Anna Rickli

1.5k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

Anna Rickli is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Anna Rickli has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Toxicology, 8 papers in Cellular and Molecular Neuroscience and 8 papers in Clinical Psychology. Recurrent topics in Anna Rickli's work include Forensic Toxicology and Drug Analysis (13 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Psychedelics and Drug Studies (8 papers). Anna Rickli is often cited by papers focused on Forensic Toxicology and Drug Analysis (13 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Psychedelics and Drug Studies (8 papers). Anna Rickli collaborates with scholars based in Switzerland. Anna Rickli's co-authors include Matthias E. Liechti, Marius C. Hoener, Linda D. Simmler, Dino Luethi, Yasmin Schmid, Eric Grouzmann, York Schramm, Evangelia Liakoni, Massimiliano Donzelli and Cédric M. Hysek and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anna Rickli

15 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

2016 277 citations Anna Rickli, Marius C. Hoener et al. European Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Rickli Switzerland	12	822	707	652	227	179	15	1.2k
Dino Luethi Switzerland	20	740 0.9×	647 0.9×	531 0.8×	290 1.3×	242 1.4×	47	1.2k
Sergio Abanades Spain	17	421 0.5×	444 0.6×	553 0.8×	173 0.8×	160 0.9×	26	1.4k
Jason Wallach United States	21	780 0.9×	636 0.9×	379 0.6×	367 1.6×	216 1.2×	32	1.2k
Karolina E. Kolaczynska Switzerland	11	502 0.6×	326 0.5×	179 0.3×	289 1.3×	48 0.3×	14	577
Katherine M. Wolfrum United States	10	319 0.4×	431 0.6×	361 0.6×	64 0.3×	162 0.9×	11	616
Mireia Segura Spain	12	521 0.6×	375 0.5×	690 1.1×	32 0.1×	78 0.4×	12	894
Shawn P. Vorce United States	18	323 0.4×	259 0.4×	595 0.9×	66 0.3×	139 0.8×	25	898
Giulio Mannocchi Italy	19	221 0.3×	172 0.2×	453 0.7×	58 0.3×	133 0.7×	33	839
Peter H. Addy United States	8	257 0.3×	221 0.3×	160 0.2×	90 0.4×	63 0.4×	10	506
F. Ivy Carroll United States	11	214 0.3×	719 1.0×	254 0.4×	75 0.3×	331 1.8×	20	1.1k

Countries citing papers authored by Anna Rickli

Since Specialization

Citations

This map shows the geographic impact of Anna Rickli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rickli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rickli more than expected).

Fields of papers citing papers by Anna Rickli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rickli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rickli. The network helps show where Anna Rickli may publish in the future.

Co-authorship network of co-authors of Anna Rickli

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rickli. A scholar is included among the top collaborators of Anna Rickli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rickli. Anna Rickli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rickli, Anna, Marius C. Hoener, & Matthias E. Liechti. (2019). Pharmacological profiles of compounds in preworkout supplements (“boosters”). European Journal of Pharmacology. 859. 172515–172515. 10 indexed citations

Rickli, Anna, Karolina E. Kolaczynska, Marius C. Hoener, & Matthias E. Liechti. (2019). Pharmacological characterization of the aminorex analogs 4-MAR, 4,4′-DMAR, and 3,4-DMAR. NeuroToxicology. 72. 95–100. 9 indexed citations

Rickli, Anna, Evangelia Liakoni, Marius C. Hoener, & Matthias E. Liechti. (2017). Opioid‐induced inhibition of the human 5‐HT and noradrenaline transportersin vitro: link to clinical reports of serotonin syndrome. British Journal of Pharmacology. 175(3). 532–543. 65 indexed citations

Steuer, Andrea E., et al.. (2016). Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans. PLoS ONE. 11(3). e0150955–e0150955. 13 indexed citations

Rickli, Anna, et al.. (2016). Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. European Neuropsychopharmacology. 26(8). 1327–1337. 277 indexed citations breakdown →

Schmid, Yasmin, Anna Rickli, Urs Duthaler, et al.. (2015). Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects. Journal of Pharmacology and Experimental Therapeutics. 353(1). 102–111. 44 indexed citations

Rickli, Anna, et al.. (2015). Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology. 99. 546–553. 165 indexed citations

Steuer, Andrea E., et al.. (2015). Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans. Drug Metabolism and Disposition. 43(12). 1864–1871. 22 indexed citations

Rickli, Anna, Marius C. Hoener, & Matthias E. Liechti. (2015). Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones. European Neuropsychopharmacology. 25(3). 365–376. 165 indexed citations

10.

Rickli, Anna, et al.. (2015). Pharmacological profile of novel psychoactive benzofurans. British Journal of Pharmacology. 172(13). 3412–3425. 86 indexed citations

11.

Dunand, M., Massimiliano Donzelli, Anna Rickli, et al.. (2014). Analytical interference of 4-hydroxy-3-methoxymethamphetamine with the measurement of plasma free normetanephrine by ultra-high pressure liquid chromatography–tandem mass spectrometry. Clinical Biochemistry. 47(12). 1121–1123. 28 indexed citations

12.

Simmler, Linda D., Anna Rickli, York Schramm, Marius C. Hoener, & Matthias E. Liechti. (2014). Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives. Biochemical Pharmacology. 88(2). 237–244. 89 indexed citations

13.

Liechti, Matthias E., Linda D. Simmler, Anna Rickli, & Marius C. Hoener. (2014). In vitro pharmacology of pipradrol derivatives, 3,4‐methylenedioxypyrovalerone, and naphyrone (1145.3). The FASEB Journal. 28(S1). 1 indexed citations

14.

Simmler, Linda D., Anna Rickli, Marius C. Hoener, & Matthias E. Liechti. (2013). Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology. 79. 152–160. 163 indexed citations

15.

Schmid, Yasmin, et al.. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British Journal of Pharmacology. 166(8). 2277–2288. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact